![]() ![]() Similar treatment regimens with anti-VEGF agents for neovascular (wet) AMD have proven difficult to maintain. in February 2023 and is administered by intravitreal (IVT) injection once every 25 to 60 days. The first treatment for GA, complement inhibitor pegcetacoplan injection, was approved in the U.S. According to published estimates, there are over one million individuals with GA in the U.S. Geographic atrophy is a highly prevalent disease with a significant unmet medical need. ![]() The transgene encoding sCFH, a shortened and optimized form of a natural inhibitor of the inflammatory complement pathway invented at the University of Pennsylvania, will be combined with 4DMT’s proprietary retinotropic R100 vector to engineer the product candidate 4D-175 for treatment of GA secondary to AMD. Continues expansion of the proprietary R100 retinotropic vector-based large-market ophthalmology portfolio beyond 4D-150 for wet AMD and diabetic macular edema (DME)ĮMERYVILLE, Calif., Ap(GLOBE NEWSWIRE) - 4D Molecular Therapeutics (Nasdaq: FDMT, “4DMT”), a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large-market diseases, today announced that it acquired the rights and know-how for short-form human complement factor H (sCFH) from Aevitas Therapeutics, Inc.CFH variants with reduced complement inhibitory function are a well-validated genetic risk factor for GA secondary to age-related macular degeneration (AMD), with approximately 75% of AMD patients carrying a high-risk variant of CFH utilizing a precision medicine approach, this population represents a potential target population for 4D-175.Announces sCFH as payload for 4D-175 lead product candidate for geographic atrophy (GA) sCFH extensively characterized in 3 genetic mouse models and in non-human primates (NHP).technology invented at University of Pennsylvania 4DMT acquires all world-wide rights to short-form human complement factor H (sCFH) from Aevitas Therapeutics, Inc. ![]() We harvest our data from various publically available data sources such as edgar database (SEC), form 5500 dataset (IRS), form 990 datasets (tax-exempt organizations) etc. We have a database of over 7.3M entities which can be searched to find the ein number of business entities. What is ?: Our website is a free resource to find the ein number for various business entities. Since all corporations - including ones with no income - must file at least a federal income tax return, a corporation operating or incorporated in the United States generally must obtain an EIN anyway either before or after being issued its charter. Also, financial institutions such as banks, credit unions, and brokerage houses will not open an account for a corporation without an EIN. To be considered a Partnership, LLC, Corporation, S Corporation, Non-profit, etc. Other commonly used terms for EIN are Taxpayer Id, IRS Number, Tax Id, Taxpayer Identification Number (TIN) etc.Ī business needs an EIN in order to pay employees and to file business tax returns. Central Index Key (CIK) is used to identify corporations who have filed disclosures and other filings with the SEC.Įmployer Identification Number (EIN): The Employer Identification Number (EIN), also known as the Federal Employer Identification Number (FEIN) or the Federal Tax Identification Number (FTIN), is a unique nine-digit number assigned by the Internal Revenue Service (IRS) (format: XX-XXXXXXXXX) to business entities operating in the United States for the purposes of identification and employment tax reporting. The CIK for 4d Molecular Therapeutics Inc is 1650648. The Central Index Key (CIK) for 4d Molecular Therapeutics Inc is 1650648.īiological Products, (no Disgnostic Substances) 4d Molecular Therapeutics Inc is incorporated in Delaware and the fiscal year end is in 31 December. It is one of the corporates which submit 10-K filings with the SEC. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. The employer identification number (EIN) for 4d Molecular Therapeutics Inc is 473506994. 4d Molecular Therapeutics Inc is a corporation in Emeryville, California. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |